Effect of different red blood cell transfusion strategies on the outcome of neurocritical patients: a randomized, controlled, clinical trial protocol
This study conforms to the principles of the Helsinki Declaration. This trial is registered at the Chinese Clinical Trial Registry (ChiCTR2400083713) on April 30, 2024. Before the study started, it was approved by the Ethics Committee of Beijing Tiantan Hospital, Capital Medical University (KY2023-116-03).
Authors
- Tianyuan Wang (ORCID: https://orcid.org/0000-0002-6976-3626)
- Ruiqi Lu (ORCID: https://orcid.org/0009-0003-6811-4960)
- Ruquan Han (ORCID: https://orcid.org/0000-0003-4335-8670)
- Weihua Cui (ORCID: https://orcid.org/0000-0003-0893-3991)
- Yuxuan Fu (ORCID: https://orcid.org/0009-0004-1718-2362)
- Yun Yu (ORCID: https://orcid.org/0000-0001-6580-9554)
Institutions
- Beijing Tian Tan Hospital (CN)
- Beijing Fengtai Hospital (CN)
Publication Details
- Journal
- Trials
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1186/s13063-025-09277-9
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bethune Charitable Foundation
- Capital Medical University